Developing Costimulatory Molecules for Immunotherapy of Diseases

Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles and interactions within the CD28 and B7 costimulatory families, with the hope that targeting these families will yield new therapies for the treatment of inflammation, autoimmunity, transplantation, cancer, and other infectious diseases. Highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy Provides the latest information on the complex roles and interactions within the CD28 and B7 costimulatory families Targets new therapies for the treatment of inflammation, autoimmunity, transplantation, cancer, and other infectious diseases

Produk Detail:

  • Author : Manzoor Ahmad Mir
  • Publisher : Academic Press
  • Pages : 322 pages
  • ISBN : 0128026758
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKDeveloping Costimulatory Molecules for Immunotherapy of Diseases

Developing Costimulatory Molecules for Immunotherapy of Diseases

Developing Costimulatory Molecules for Immunotherapy of Diseases
  • Author : Manzoor Ahmad Mir
  • Publisher : Academic Press
  • Release : 25 May 2015
GET THIS BOOKDeveloping Costimulatory Molecules for Immunotherapy of Diseases

Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles and interactions within the CD28

Immunotherapy of Cancer

Immunotherapy of Cancer
  • Author : Anonim
  • Publisher : Academic Press
  • Release : 13 June 2019
GET THIS BOOKImmunotherapy of Cancer

Immunotherapy of Cancer, Volume 143, the latest release in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research. Contributions from leading experts in the field make this a must have update on the topic. Provides that latest information on cancer research Offers outstanding and original reviews on a range of cancer research topics Serves as an indispensable reference for researchers and students alike

Human Pathogenic Microbes

Human Pathogenic Microbes
  • Author : Manzoor Ahmad Mir
  • Publisher : Academic Press
  • Release : 25 March 2022
GET THIS BOOKHuman Pathogenic Microbes

Considering the global emerging human pathogenic microbial diseases and trends, Human Pathogenic Microbes is framed to provide deep insights into the epidemic and emerging bacterial and fungal infections and diseases in humans. It presents novel, up-to-date, and cutting-edge knowledge regarding various human pathogenic microbes, their associated drug resistance mechanisms, and different diseases caused by them. Human Pathogenic Microbes reflects the current research and development on the evolution of bacterial and fungal drug resistance: different bacterial and fungal antimicrobial drug resistance

Regulation of Cancer Immune Checkpoints

Regulation of Cancer Immune Checkpoints
  • Author : Jie Xu
  • Publisher : Springer Nature
  • Release : 17 March 2020
GET THIS BOOKRegulation of Cancer Immune Checkpoints

This book systematically reviews the most important findings on cancer immune checkpoints, sharing essential insights into this rapidly evolving yet largely unexplored research topic. The past decade has seen major advances in cancer immune checkpoint therapy, which has demonstrated impressive clinical benefits. The family of checkpoints for mediating cancer immune evasion now includes CTLA-4, PD-1/PD-L1, CD27/CD70, FGL-1/LAG-3, Siglec-15, VISTA (PD-1L)/VSIG3, CD47/SIRPA, APOE/LILRB4, TIGIT, and many others. Despite these strides, most patients do not

Nanoformulation Strategies for Cancer Treatment

Nanoformulation Strategies for Cancer Treatment
  • Author : Sarwar Beg,Mahfoozur Rahman,Hani Choudhry,Eliana B. Souto,Farhan J. Ahmad
  • Publisher : Elsevier
  • Release : 20 November 2020
GET THIS BOOKNanoformulation Strategies for Cancer Treatment

Nanoformulation Strategies for Cancer Treatment provides an up-to-date review on current developments and regulatory and clinical challenges in the field of nanopharmaceuticals and the effective treatment of diverse varieties of cancer. This important reference source is ideal for biomaterials scientists and pharmaceutical scientists working in the area of cancer diagnosis and therapy. Due to the high cost of traditional cancer treatment types, researchers have increasingly looked for new ways to augment the therapeutic performance of existing drug candidates. The use

Immunogenetics: A Molecular and Clinical Overview

Immunogenetics: A Molecular and Clinical Overview
  • Author : Muneeb U. Rehman,Azher Arafah,Md. Niamat Ali,Shafat Ali
  • Publisher : Academic Press
  • Release : 30 November 2021
GET THIS BOOKImmunogenetics: A Molecular and Clinical Overview

A Molecular Approach to Immunogenetics, Immunogenetics: A Molecular and Clinical Overview, Volume One provides readers with an exclusive, updated overview on the scientific knowledge, achievements and findings in the field of immunogenetics. The book presents readily available, updated information on the molecular and clinical aspects of immunogenetics, from origin and development to clinical applications and future prospects. The breadth of information goes from basics to developments, clinical applications and future prospects. The book's most attractive attribute is its academic and

Immuno-Oncology Crosstalk and Metabolism

Immuno-Oncology Crosstalk and Metabolism
  • Author : Muzafar Ahmad Macha,Ajaz Ahmad Bhat,Nissar Ahmad Wani
  • Publisher : Springer Nature
  • Release : 17 June 2022
GET THIS BOOKImmuno-Oncology Crosstalk and Metabolism

This book discusses the novel metabolic cross-talk between immune and tumor cells in the tumor microenvironment that promotes their growth and progression. It also describes deregulated metabolism in cancer cells that promotes suppressive and cancer cell-favourable microenvironment. Further, the book provides novel insights on the metabolic changes in immune cells that promote tumor cell growth and survival. In turn, it also reviews the involvement of immuno-onco metabolic cross-talk in the development of resistance to chemo-radiation therapy (CRT) in tumor cells.

The Cytokines of the Immune System

The Cytokines of the Immune System
  • Author : Zlatko Dembic
  • Publisher : Academic Press
  • Release : 23 May 2015
GET THIS BOOKThe Cytokines of the Immune System

The Cytokines of the Immune System catalogs cytokines and links them to physiology and pathology, providing a welcome and hugely timely tool for scientists in all related fields. In cataloguing cytokines, it lists their potential for therapeutic use, links them to disease treatments needing further research and development, and shows their utility for learning about the immune system. This book offers a new approach in the study of cytokines by combining detailed guidebook-style cytokine description, disease linking, and presentation of

Combinational Therapy in Triple Negative Breast Cancer

Combinational Therapy in Triple Negative Breast Cancer
  • Author : Manzoor Ahmad Mir
  • Publisher : Academic Press
  • Release : 12 May 2022
GET THIS BOOKCombinational Therapy in Triple Negative Breast Cancer

Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level with a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance; combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases

Immunotherapy of Hepatocellular Carcinoma

Immunotherapy of Hepatocellular Carcinoma
  • Author : Tim F. Greten
  • Publisher : Springer
  • Release : 04 October 2017
GET THIS BOOKImmunotherapy of Hepatocellular Carcinoma

In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of

Costimulation Immunotherapy for Autoimmunity, Transplantation and Lymphomas

Costimulation Immunotherapy for Autoimmunity, Transplantation and Lymphomas
  • Author : Manzoor Ahmad Mir,Raid S. Al Baradie,Abdul Rahman Obaid Alharbi
  • Publisher : Unknown Publisher
  • Release : 24 May 2022
GET THIS BOOKCostimulation Immunotherapy for Autoimmunity, Transplantation and Lymphomas

Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem worldwide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumor suppressors and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective

Regulatory T Cells in Health and Disease

Regulatory T Cells in Health and Disease
  • Author : Anonim
  • Publisher : Academic Press
  • Release : 26 November 2015
GET THIS BOOKRegulatory T Cells in Health and Disease

Regulatory T Cells in Health and Disease focuses on the mechanism by which T cells become regulatory T cells, the processes which control the number of regulatory T cells in the blood and tissue, and the ways in which regulatory T cell prevent autoimmune disease and interact with infections and cancer. Contains contributions from leading authorities in the field of regulatory T cell biology Informs and updates on all the latest developments in the field Explores the processes which control

Immunotherapy

Immunotherapy
  • Author : Krassimir Metodiev
  • Publisher : BoD – Books on Demand
  • Release : 26 April 2017
GET THIS BOOKImmunotherapy

This is another attempt of InTechOpen to continue the dissemination of international knowledge and experience in the field of immunology. The present book includes a number of modern concepts of specialists and experts in the field of immunotherapy, covering the major topics and analyzing the history, current stage, and future ideas of application of modern immunomodulation. It is always a benefit, but also a compliment, to gather a team of internationally distinguished authors and to motivate them to reveal their

Reverse Costimulation in the Treatment of Infectious Diseases

Reverse Costimulation in the Treatment of Infectious Diseases
  • Author : Manzoor Ahmad Mir
  • Publisher : Nova Science Pub Incorporated
  • Release : 26 January 2014
GET THIS BOOKReverse Costimulation in the Treatment of Infectious Diseases

Cancer is one of the most prominent causes of mortality in children and adults causing about 9 million deaths annually, is a major health problem world-wide. The transformation of normal cells to cancer cells may arise due to dysregulation of oncogenes, tumour suppressers and/or stability genes. These transformed cells are sensed by the cells of the immune system, especially T cells, through specific receptors for an effective immune response. But unfortunately even after the interaction with T cells, an effective